This clinical trial aims to evaluate the effectiveness of a new medication for managing chronic pain. Participants will receive either the investigational drug or a placebo to compare outcomes.
- Who Can Participate: Adults aged 18-65 with a diagnosis of chronic pain for at least six months
- Study Details: Participants will be randomly assigned to receive either the new medication or a placebo, with regular assessments to monitor progress
- Study Timelines and Visits: The study will last 12 weeks.The study requires 5 visits